Back

Is there a significant 1-year impact on tricuspid valve regurgitation evolution in leadless-PM implanted subjects?

28 August 2023 (10:15 - 10:50)
Organised by: Logo
Congress Presentation Part of: Devices and outcomes of ventricular arrhythmias Device Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Antonella Sabatini

Florence (Italy)

6 More presentations in this session

Presentation thumbnail
Clinical outcome for heart failure hospitalizations in patients with leadless pacemaker
Doctor M. Nagashima (Kitakyushu, JP)
Abstract Slides Video
Presentation thumbnail
Permanent pacemaker implantations among patients with spinal cord injury in the United States
Doctor G. Margolis (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Clinical and echocardiographic impact of physiological estimulation in patients with preserved ejection fraction: a randomized clinical trial
Mr O. Rodriguez Queralto (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: data from the SMASH Study
Doctor N. Sourour (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Clinical genetic testing in arrhythmogenic mitral valve prolapse syndrome highlights a potential overlap with familial dilated cardiomyopathy
Doctor J. Giudicessi (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Devices and outcomes of ventricular arrhythmias

The Event

Event poster

ESC Congress 2023

28 August 2023 10:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources